$71.23
-0.01-0.01%
Last update: Nov 9, 4:14 PM
National Health Investors Inc
NHINYSE
National Health Investors (NHI) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
National Health Investors (NHI) last issued guidance on November 9, 2026 for fiscal year 2026. The company guided earnings per share in the range of $4.68 - $4.7, compared to a consensus EPS estimate of $4.76.
Compared to prior guidance, National Health Investors lowered its EPS outlook from a previous range of $4.74 - $4.79.
National Health Investors has issued 16 guidance updates between February 21, 2023 and November 9, 2026. During this period, the company raised its outlook 8 times and lowered it 5 times, providing investors with insight into management's evolving expectations.
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $1.17 | $1.26 | $1.21 | $0.97 |
| Actual | $1.12 | $1.19 | $1.23 | $1.22 |
| Surprise | -4.27% | -5.56% | +1.65% | +25.8% |
| Revenue | ||||
| Estimate | $113.1M | $113.6M | $106.0M | $96.6M |
| Actual | $113.5M | $121.3M | $115.1M | $105.8M |
| Surprise | +0.30% | +6.79% | +8.64% | +9.54% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $1.16 | $1.22 | $1.24 | $1.27 |
| Revenue | ||||
| Consensus | $114.7M | — | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 9, 2026 | $1.12 | $1.17 | -4.27 % |
| Q2 | Aug 10, 2026 | $1.19 | $1.26 | -5.56 % |
| Q1 | May 4, 2026 | $1.23 | $1.21 | 1.65 % |
| Q4 | Feb 26, 2026 | $1.22 | $0.97 | 25.8 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Nov 9, 2026 | $113.48M | $113.15M | 0.30 % |
| Q2 | Aug 10, 2026 | $121.32M | $113.61M | 6.79 % |
| Q1 | May 4, 2026 | $115.13M | $105.97M | 8.64 % |
| Q4 | Feb 26, 2026 | $105.82M | $96.60M | 9.54 % |
